The five possible suitors circling around the high growth SRX are Cephalon., Roche, Sanofi, Genentech and Pfizer. All five have in common lower margin businesses versus very high SRX 80% gross margin business. All also have complementary chemotherapy drugs that work well in extending survival times by over 100% in many cases with the use of Sirtex Sir Spheres. AT 10x eps with growth between 70-100%, SRX wont be this low for very long. The PEG ratio of 10/70=.14 is the lowest of biotechs, as most biotechs sell at PEG ratios of 1-2. I am adding more shares as I did 2 weeks ago.My little opinion only after being in industry for over 30 yrs.Do your own work
- Forums
- ASX - By Stock
- SRX
- the five suitors of srx
the five suitors of srx
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.5¢ | $106.5K | 608.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28520 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 1305905 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28520 | 0.175 |
5 | 1608822 | 0.170 |
1 | 18186 | 0.165 |
1 | 11500 | 0.135 |
1 | 2577 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 1305905 | 31 |
0.185 | 38427 | 3 |
0.190 | 220025 | 8 |
0.195 | 20478 | 2 |
0.200 | 527416 | 8 |
Last trade - 10.30am 30/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |